Pharmaceutical Market Trends, 2007 - 2011

"The global pharmaceutical market grew to US$643 billion in 2006, growing at a compound annual growth rate (CAGR) of 10.0% between 1999 and 2006. However, year-on-year growth slowed to 6.8% in 2006, largely as a result of increased competition from generic products and the effects of continued healthcare cost containment across major markets."

Pharmaceutical Market Trends, 2007 - 2011: Key market forecasts & growth opportunities presents a detailed trend analysis of the global pharmaceutical market as at the end of 2006 and forecasts until 2011. The 173 page report presents a series of market forecasts and growth opportunities in order to help inform pharmaceutical decision-making, particularly in the areas of corporate planning, portfolio management and market forecasting.

The data and analysis contained within the report are comprehensive, consistent and up-to-date in order to provide a single-point reference for understanding key pharmaceutical market trends in 2007.

Headline Findings

The global pharmaceutical market is forecast to grow to US$897 billion in 2011, an equivalent CAGR of 6.9% over the next five years.

Strong growth in the 10 European markets that joined the European Union in 2004 will help to boost European sales over the next five years.

In 2006 the leading therapy areas by sales were cardiovascular with 14.2% share and CNS with 14.1%.

Continued double-digit market growth in China will make it the seventh biggest drug market by sales in 2010.

The top 100 blockbuster drugs generated sales of US$232.2 billion accounting for 36% of the total pharma market.

Total pharmaceutical sales from the top 10 companies accounted for more than 40% of the total market.

KEY FEATURES OF THE REPORT

> Comprehensive market trends for key countries, regions, therapy areas, products and companies.

> Country profiles for leading pharma markets with market segment trends and 5 year forecasts.

> Therapy area profiles for leading therapeutic classes and key products and 2010 sales forecasts.

> Detailed profiles of 10 leading pharmaceutical products in 2006, including five year future sales forecasts.

> Detailed profiles of 10 leading pharmaceutical companies in 2006, including 2011 sales forecasts.(AstraZeneca, Eli Lilly, GlaxoSmithKline, Johnson and Johnson, Merck & Co, Novartis, Pfizer, Roche, Sanofi-Aventis Wyeth)

173 pages long, with 87 figures and 67 tables to illustrate the market trends.

USE THIS REPORT TO:

1. Benchmark your portfolio against key market trends and forecasts in order to plan better for success.

2. Identify key areas of pharmaceutical market growth and key opportunities for delivering successful sales growth over the next five years.

3. Support internal planning and decision-making with an external perspective founded on detailed analysis and transparent market forecasts.

REPORT COVERAGE

The report methodology provides a detailed but transparent analysis of key pharmaceutical market trends, including key markets, therapy areas, products and companies. Historical trends are formed over a three-year time horizon and future forecasts are made using a five-year future time period. Thus, the data and analysis relate to the nine-year time horizon from 2003 to 2011.

All data used in outlining historical trends is clearly sourced within the report and any data limitations or additional assumptions are explicitly detailed within the text of the report. Future market forecasts are projected based on both historical trends and future expectations over market conditions and events. The assumptions used to form the basis of key market forecasts are outlined in detail within the text of the report.

Author S. Seget

Publication date: November 2007

Pages: 173 Format: PDF

The Author - Steven Seget is Principal at Delphi Pharma, and provides independent strategic consulting services to the pharmaceutical and biotechnology industries.

Delphi Pharma provides strategic, financial and market–based solutions to clients, focusing primarily on the portfolio management and licensing functions.
Tabl eof Contents
Price: $2,050.00 / GBP1,025.00